Acoramidis shows potential to be effective, safe treatment for transthyretin amyloid cardiomyopathy

Acoramidis improves outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) compared with placebo, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

GoodRx Launches E-commerce Solution with Opill

What You Should Know: – GoodRx, a leading prescription savings platform in the U.S., is expanding its offerings with the launch of a new e-commerce

October 31, 2024

J&J cuts the price of its lifesaving TB pill by more than half for many low- and middle-income countries

Amid controversy over access to a lifesaving tuberculosis pill, a new contracting effort is expected to lower the price for the medicine by as much

August 30, 2023

Moderate choline intake lowers heart disease risk

A recent study from BMC Public Health found that moderate dietary choline intake is associated with a reduced risk of atherosclerotic cardiovascular disease (ASCVD) among

June 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.